210 related articles for article (PubMed ID: 35806362)
41. Role of de novo donor-specific anti-HLA antibodies in kidney graft failure: A case-control study.
Castro A; Malheiro J; Tafulo S; Dias L; Martins LS; Fonseca I; Beirão I; Castro-Henriques A; Cabrita A
HLA; 2017 Nov; 90(5):267-275. PubMed ID: 28776960
[TBL] [Abstract][Full Text] [Related]
42. Human leukocyte antigen eplet mismatching is associated with increased risk of graft loss and rejection after pediatric heart transplant.
Albers EL; Friedland-Little JM; Hong BJ; Kemna MS; Warner P; Law YM
Pediatr Transplant; 2022 Feb; 26(1):e14126. PubMed ID: 34476876
[TBL] [Abstract][Full Text] [Related]
43. Molecular Mismatch Predicts T Cell-Mediated Rejection and De Novo Donor-Specific Antibody Formation After Living Donor Liver Transplantation.
Ono K; Ide K; Tanaka Y; Ohira M; Tahara H; Tanimine N; Yamane H; Ohdan H
Liver Transpl; 2021 Nov; 27(11):1592-1602. PubMed ID: 34310028
[TBL] [Abstract][Full Text] [Related]
44. De Novo DQ Donor-Specific Antibodies Are Associated with Chronic Lung Allograft Dysfunction after Lung Transplantation.
Tikkanen JM; Singer LG; Kim SJ; Li Y; Binnie M; Chaparro C; Chow CW; Martinu T; Azad S; Keshavjee S; Tinckam K
Am J Respir Crit Care Med; 2016 Sep; 194(5):596-606. PubMed ID: 26967790
[TBL] [Abstract][Full Text] [Related]
45. Which is the best predictor of de novo donor-specific antibodies in a cohort of non-sensitized first kidney transplantation: Antigenic, allelic, epitope, or physiochemical HLA mismatches?
Delion A; Girerd S; Duarte K; Girerd N; Schikowski J; Kessler M; Frimat L; Aarnink A
Clin Transplant; 2019 Apr; 33(4):e13508. PubMed ID: 30821002
[TBL] [Abstract][Full Text] [Related]
46. Clinical impact of complement (C1q, C3d) binding De Novo donor-specific HLA antibody in kidney transplant recipients.
Lee H; Han E; Choi AR; Ban TH; Chung BH; Yang CW; Choi YJ; Oh EJ
PLoS One; 2018; 13(11):e0207434. PubMed ID: 30427941
[TBL] [Abstract][Full Text] [Related]
47. Solid-Phase C1q/C3d Fixing Readouts Correlate with High Median Fluorescence Intensity (MFI) De Novo Donor-Specific HLA Antibodies and C4d⁺ Antibody-Mediated Rejection in Kidney Transplant Recipients.
Tatapudi VS; Kopchaliiska D; da Gente GJ; Buenaventura OF; Singh M; Laszik Z; Adey DB; Rajalingam R
Ann Transplant; 2021 Dec; 26():e934175. PubMed ID: 34848674
[TBL] [Abstract][Full Text] [Related]
48. Combined impact of the inter and intra-patient variability of tacrolimus blood level on allograft outcomes in kidney transplantation.
Park Y; Lee H; Eum SH; Ko EJ; Min JW; Yoon SH; Hwang WM; Yun SR; Yang CW; Shin J; Chung BH
Front Immunol; 2022; 13():1037566. PubMed ID: 36466843
[TBL] [Abstract][Full Text] [Related]
49. Eplet matching in pediatric heart transplantation: The SickKids experience.
Cardoso B; Wang J; Kiernan J; Dipchand AI
J Heart Lung Transplant; 2022 Oct; 41(10):1470-1477. PubMed ID: 35933296
[TBL] [Abstract][Full Text] [Related]
50. hlaR: A rapid and reproducible tool to identify eplet mismatches between transplant donors and recipients.
Johnson AC; Zhang J; Cliff Sullivan H; Wiebe C; Bray R; Gebel H; Larsen CP
Hum Immunol; 2022 Mar; 83(3):248-255. PubMed ID: 35101308
[TBL] [Abstract][Full Text] [Related]
51. Incidence and impact of de novo donor-specific alloantibody in primary renal allografts.
Everly MJ; Rebellato LM; Haisch CE; Ozawa M; Parker K; Briley KP; Catrou PG; Bolin P; Kendrick WT; Kendrick SA; Harland RC; Terasaki PI
Transplantation; 2013 Feb; 95(3):410-7. PubMed ID: 23380861
[TBL] [Abstract][Full Text] [Related]
52. HLA molecular epitope mismatching and long-term graft loss in pediatric heart transplant recipients.
Sullivan PM; Warner P; Kemna MS; Albers EL; Law SP; Weiss NS; Law YM
J Heart Lung Transplant; 2015 Jul; 34(7):950-7. PubMed ID: 25727771
[TBL] [Abstract][Full Text] [Related]
53. Impact of low tacrolimus exposure and high tacrolimus intra-patient variability on the development of
Mendoza Rojas A; Hesselink DA; van Besouw NM; Baan CC; van Gelder T
Expert Rev Clin Immunol; 2019 Dec; 15(12):1323-1331. PubMed ID: 31721605
[No Abstract] [Full Text] [Related]
54. Within-Patient Variability in Tacrolimus Blood Levels Predicts Kidney Graft Loss and Donor-Specific Antibody Development.
Rodrigo E; Segundo DS; Fernández-Fresnedo G; López-Hoyos M; Benito A; Ruiz JC; de Cos MA; Arias M
Transplantation; 2016 Nov; 100(11):2479-2485. PubMed ID: 26703349
[TBL] [Abstract][Full Text] [Related]
55. Results of early treatment for de novo donor-specific antibodies in pediatric kidney transplant recipients in a cross-sectional and longitudinal cohort.
Charnaya O; Tuchman S; Moudgil A
Pediatr Transplant; 2018 Mar; 22(2):. PubMed ID: 29356221
[TBL] [Abstract][Full Text] [Related]
56. The Utility of Donor-specific Antibody Monitoring and the Role of Kidney Biopsy in Simultaneous Liver and Kidney Recipients With De Novo Donor-specific Antibodies.
Parajuli S; Aziz F; Blazel J; Muth BL; Garg N; Mohamed M; Rice J; Mezrich JD; Hidalgo LG; Mandelbrot D
Transplantation; 2021 Jul; 105(7):1548-1555. PubMed ID: 32732618
[TBL] [Abstract][Full Text] [Related]
57. Estimation of Antibody-Verified Eplet Mismatch Load, 2-Field HLA Resolution vs Imputation in a Large Cohort of European Donors.
Renuncio-García M; González-López E; Carreras E; Villa J; Romón-Alonso I; Roa-Bautista A; Gutiérrez-Larrañaga M; Comins-Boo A; Irure-Ventura J; López-Hoyos M; San Segundo D
Transplant Proc; 2022 Nov; 54(9):2414-2418. PubMed ID: 36333253
[TBL] [Abstract][Full Text] [Related]
58. De novo donor-specific human leukocyte antigen antibodies early after kidney transplantation.
Heilman RL; Nijim A; Desmarteau YM; Khamash H; Pando MJ; Smith ML; Chakkera HA; Huskey J; Valdez R; Reddy KS
Transplantation; 2014 Dec; 98(12):1310-5. PubMed ID: 24879384
[TBL] [Abstract][Full Text] [Related]
59. Exploratory associations of tacrolimus exposure and clinical outcomes after lung transplantation: A retrospective, single center experience.
Du W; Wang X; Zhang D; Zuo X
Eur J Clin Pharmacol; 2024 May; 80(5):747-757. PubMed ID: 38363388
[TBL] [Abstract][Full Text] [Related]
60. HLA-DR and -DQ eplet mismatches and transplant glomerulopathy: a nested case-control study.
Sapir-Pichhadze R; Tinckam K; Quach K; Logan AG; Laupacis A; John R; Beyene J; Kim SJ
Am J Transplant; 2015 Jan; 15(1):137-48. PubMed ID: 25521856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
